臺灣博碩士論文加值系統

Epstein-Barr Virus (EBV) 是一種廣泛存在於人類的疱疹病毒(herpes virus)，與許多人類惡性腫瘤有關，如伯奇氏淋巴瘤 (Burkett’s lymphoma) 及鼻咽癌 (nasopharyngeal carcinoma) 等。前人的結果顯示，EBV有八個潛伏蛋白質 (latent protein) 與B細胞的轉形癌化有關，其中之一即是EBNA2，EBNA2是一個轉錄活化子，可以在轉殖鼠中，誘發腫瘤形成。雖然先前的研究顯示EBNA2轉錄活化的功能與其引起細胞轉形癌化的功能有關，但是EBNA2如何引起腫瘤的相關機制目前還不清楚。
過去我們實驗室曾報導，EBNA2可能會藉著活化p53刺激p21的表現，進而讓上皮細胞生長停滯。為了更進一步了解EBNA2對細胞增殖的影響，我們利用流式細胞儀來分析EBNA2會使細胞停滯在哪一個時期，結果發現EBNA2會使細胞週期停滯在G2/M phase。為了更精確的知道EBNA2是影響細胞週期的G2 phase或M phase，藉著分析M phase的標記蛋白質phospho-Histone H3後，我們確定EBNA2會讓細胞停滯在G2 phase。這個結論也由分析Cdk1活化的時間點得到證明。
之前的文獻中指出，當細胞生長停滯在G2 phase時，常常會伴隨著多套體及多核的產生。由於EBNA2會讓細胞週期停滯在G2 phase，因此我們偵測EBNA2是否會讓細胞形成多套體。我們利用流式細胞儀分析發現，EBNA2的確能引起多套體的產生。為了解EBNA2引起多套體的機制，我們想知道EBNA2是否會干擾mitotic spindle checkpoint。藉著分析Histone-H3的磷酸化狀態以及mitotic index，我們發現EBNA2的確會干擾spindle checkpoint。EBNA2有可能藉由干擾mitotic spindle checkpoint讓染色體無法平均的分配到子細胞中。這些帶有不正常染色體的細胞進行再複製後，即會造成多套體。
綜合以上結果我們發現，EBNA2具有一個未被發現的新功能，就是它會引起細胞基因體的不穩定。我們相信EBNA2的這個功能，對於EBNA2引起腫瘤的形成是非常重要的。

Epstein-Barr Virus (EBV) is a herpesvirus which exists commonly in the human population and has been shown to be associated with many human malignancies, notably Burkett’s lymphoma and nasopharyngeal carcinoma. Eight latent proteins of EBV have been shown to be critical for EBV transformation of B-cells. Among them, EBV nuclear antigen 2 (EBNA2), a transcriptional activator, has been shown to be able to induce tumor in transgenic mice. Although the transactivation function of EBNA2 has been proposed to contribute to its transformation function, the mechanism underlying EBNA2 tumor-inducing function remains unclear.
Previously we reported that EBNA2 can retard epithelial cell growth possibly through stimulating p53 activity and inducing p21 expression. To further investigate the effects of EBNA2 on cell proliferation, we used flow cytometric analysis to determine which phase of cell cycle was affected by EBNA2. We found that EBNA2 could retard cell cycle progression at G2/M phase. To more specifically pinpoint whether G2 or M phase was affected by EBNA2, we measured the phosphorylation status of histone H3 after cells were released from G1/S block. Our data indicated that EBNA2 specifically retarded cell cycle progression at G2 phase. This conclusion was also confirmed by the data that measured the phosphorylation status of Cdk1 after cells were released from G1/S block.
Previous studies indicated that agents that induce cell cycle G2 arrest often cause cells to become polyploid and contain multinuclei. Since EBNA2 could induce G2 arrest, we also test whether EBNA2 could induce polyploidy. Indeed, we found that EBNA2 could induce polyploidy by flow cytometric analysis. To investigate the mechanism underlying EBNA2 induction of polyploidy, we asked whether EBNA2 could disrupt mitotic spindle checkpoint. By analyzing the phosphorylation status of histone H3 and mitotic index, we found that EBNA2 indeed could disrupt the mitotic spindle checkpoint. Through disrupting spindle checkpoint, EBNA2 may cause chromosomes to be unevenly divided into daughter cells. Polyploidy cells may then arise after endoreduplication of these unevenly divided chromosomes.
Multinucleation is frequently accompanied with disruption of spindle checkpoint and polyploidy. We also found that many EBNA2-expressing cells contained multinuclei. Together, the above data reveal a novel function of EBNA2, that is, its ability to induce genome instability. We believe that this function of EBNA2 may be more important than other known functions of EBNA2 in inducing tumor formation.

中文摘要……………………………………………………………… 1
英文摘要……………………………………………………………… 3
序言…………………………………………………………………… 5
研究目標………………………………………………………………17
材料與方法……………………………………………………………18
結果……………………………………………………………………30
討論……………………………………………………………………41
附圖……………………………………………………………………48
參考資料………………………………………………………………74

Ambinder, R.F., Shah, W.A., Rawlins, D.R., Hayward, G.S. and Hayward, S.D. (1990) Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J Virol, 64, 2369-2379.
Amon, A. (1999) The spindle checkpoint. Curr Opin Genet Dev, 9, 69-75.
Andreassen, P.R., Lohez, O.D., Lacroix, F.B. and Margolis, R.L. (2001) Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell, 12, 1315-1328.
Babcock, G.J., Decker, L.L., Volk, M. and Thorley-Lawson, D.A. (1998) EBV persistence in memory B cells in vivo. Immunity, 9, 395-404.
Bahar, R., J, O.W., Kawamura, K., Seimiya, M., Wang, Y., Hatano, M., Okada, S., Tokuhisa, T., Watanabe, T. and Tagawa, M. (2002) Growth retardation, polyploidy, and multinucleation induced by Clast3, a novel cell cycle-regulated protein. J Biol Chem, 277, 40012-40019.
Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K. and Vogelstein, B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915.
Bartek, J. and Lukas, J. (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol, 13, 738-747.
Bartz, S.R., Rogel, M.E. and Emerman, M. (1996) Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol, 70, 2324-2331.
Bischoff, J.R. and Plowman, G.D. (1999) The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol, 9, 454-459.
Booher, R.N., Holman, P.S. and Fattaey, A. (1997) Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem, 272, 22300-22306.
Borza, C.M. and Hutt-Fletcher, L.M. (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med, 8, 594-599.
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W. and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science, 282, 1497-1501.
Burke, D.J. (2000) Complexity in the spindle checkpoint. Curr Opin Genet Dev, 10, 26-31.
Burma, S., Chen, B.P., Murphy, M., Kurimasa, A. and Chen, D.J. (2001) ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem, 276, 42462-42467.
Cesarman, E. and Mesri, E.A. (1999) Virus-associated lymphomas. Curr Opin Oncol, 11, 322-332.
Chang, Y., Tung, C.H., Huang, Y.T., Lu, J., Chen, J.Y. and Tsai, C.H. (1999) Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol, 73, 8857-8866.
Connor, C.G. and Brownstein, B.L. (1981) The presence of SV40 T-antigen is not required for cytochalasin B-induced multinucleation. Cell Biol Int Rep, 5, 1027-1031.
Deng, C., Zhang, P., Harper, J.W., Elledge, S.J. and Leder, P. (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82, 675-684.
Dunphy, W.G. and Kumagai, A. (1991) The cdc25 protein contains an intrinsic phosphatase activity. Cell, 67, 189-196.
el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
Fahraeus, R., Palmqvist, L., Nerdstedt, A., Farzad, S., Rymo, L. and Lain, S. (1994) Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity. Embo J, 13, 6041-6051.
Flatt, P.M., Tang, L.J., Scatena, C.D., Szak, S.T. and Pietenpol, J.A. (2000) p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol Cell Biol, 20, 4210-4223.
Fode, C., Binkert, C. and Dennis, J.W. (1996) Constitutive expression of murine Sak-a suppresses cell growth and induces multinucleation. Mol Cell Biol, 16, 4665-4672.
Frech, B., Zimber-Strobl, U., Yip, T.T., Lau, W.H. and Mueller-Lantzsch, N. (1993) Characterization of the antibody response to the latent infection terminal proteins of Epstein-Barr virus in patients with nasopharyngeal carcinoma. J Gen Virol, 74 (Pt 5), 811-818.
Gautier, J., Solomon, M.J., Booher, R.N., Bazan, J.F. and Kirschner, M.W. (1991) cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell, 67, 197-211.
Glotzer, M., Murray, A.W. and Kirschner, M.W. (1991) Cyclin is degraded by the ubiquitin pathway. Nature, 349, 132-138.
Grogan, E., Jenson, H., Countryman, J., Heston, L., Gradoville, L. and Miller, G. (1987) Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Proc Natl Acad Sci U S A, 84, 1332-1336.
Grundhoff, A.T., Kremmer, E., Tureci, O., Glieden, A., Gindorf, C., Atz, J., Mueller-Lantzsch, N., Schubach, W.H. and Grasser, F.A. (1999) Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C. J Biol Chem, 274, 19136-19144.
Guo, Z., Kumagai, A., Wang, S.X. and Dunphy, W.G. (2000) Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev, 14, 2745-2756.
Hartwell, L.H. and Weinert, T.A. (1989) Checkpoints: controls that ensure the order of cell cycle events. Science, 246, 629-634.
Hendzel, M.J., Wei, Y., Mancini, M.A., Van Hooser, A., Ranalli, T., Brinkley, B.R., Bazett-Jones, D.P. and Allis, C.D. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma, 106, 348-360.
Hermeking, H., Lengauer, C., Polyak, K., He, T.C., Zhang, L., Thiagalingam, S., Kinzler, K.W. and Vogelstein, B. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell, 1, 3-11.
Hinchcliffe, E.H. and Sluder, G. (2001) "It takes two to tango": understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev, 15, 1167-1181.
Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I. and Weinberg, R.A. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70, 993-1006.
Hirao, A., Kong, Y.Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S.J. and Mak, T.W. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science, 287, 1824-1827.
Hwang, A. and Muschel, R.J. (1998) Radiation and the G2 phase of the cell cycle. Radiat Res, 150, S52-59.
Jayachandra, S., Low, K.G., Thlick, A.E., Yu, J., Ling, P.D., Chang, Y. and Moore, P.S. (1999) Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc Natl Acad Sci U S A, 96, 11566-11571.
Johannsen, E., Koh, E., Mosialos, G., Tong, X., Kieff, E. and Grossman, S.R. (1995) Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol, 69, 253-262.
Johnson, D.G. and Walker, C.L. (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol, 39, 295-312.
Jordan, M.A., Thrower, D. and Wilson, L. (1992) Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci, 102 (Pt 3), 401-416.
Kieff, E. and Rickinson, A.B. (2001) Epstein-Barr Virus and Its Replication. Fields Virology, 2, 2511-2575.
Kinzler, K.W. and Vogelstein, B. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761, 763.
Kuriyama, R., Gustus, C., Terada, Y., Uetake, Y. and Matuliene, J. (2002) CHO1, a mammalian kinesin-like protein, interacts with F-actin and is involved in the terminal phase of cytokinesis. J Cell Biol, 156, 783-790.
Laux, G., Adam, B., Strobl, L.J. and Moreau-Gachelin, F. (1994) The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. Embo J, 13, 5624-5632.
Lee, J.M., Lee, K.H., Weidner, M., Osborne, B.A. and Hayward, S.D. (2002) Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis. Proc Natl Acad Sci U S A, 99, 11878-11883.
Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649.
Lin, C.S., Kuo, H.H., Chen, J.Y., Yang, C.S. and Wang, W.B. (2000) Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally. J Mol Biol, 303, 7-23.
Lin, C.T., Wong, C.I., Chan, W.Y., Tzung, K.W., Ho, J.K., Hsu, M.M. and Chuang, S.M. (1990) Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest, 62, 713-724.
Ling, P.D. and Hayward, S.D. (1995) Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J Virol, 69, 1944-1950.
Ling, P.D., Hsieh, J.J., Ruf, I.K., Rawlins, D.R. and Hayward, S.D. (1994) EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol, 68, 5375-5383.
Ling, P.D., Ryon, J.J. and Hayward, S.D. (1993) EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J Virol, 67, 2990-3003.
Lo, K.W. and Huang, D.P. (2002) Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol, 12, 451-462.
Lopez-Girona, A., Furnari, B., Mondesert, O. and Russell, P. (1999) Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature, 397, 172-175.
Lukas, J., Lukas, C. and Bartek, J. (2004) Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst), 3, 997-1007.
Lundberg, A.S. and Weinberg, R.A. (1999) Control of the cell cycle and apoptosis. Eur J Cancer, 35, 1886-1894.
Lundgren, K., Walworth, N., Booher, R., Dembski, M., Kirschner, M. and Beach, D. (1991) mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell, 64, 1111-1122.
Martinez, J., Georgoff, I., Martinez, J. and Levine, A.J. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev, 5, 151-159.
Matsuoka, S., Huang, M. and Elledge, S.J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 282, 1893-1897.
Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kato, J.Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol, 14, 2066-2076.
Minoshima, Y., Kawashima, T., Hirose, K., Tonozuka, Y., Kawajiri, A., Bao, Y.C., Deng, X., Tatsuka, M., Narumiya, S., May, W.S., Jr., Nosaka, T., Semba, K., Inoue, T., Satoh, T., Inagaki, M. and Kitamura, T. (2003) Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during cytokinesis. Dev Cell, 4, 549-560.
Mishima, M., Kaitna, S. and Glotzer, M. (2002) Central spindle assembly and cytokinesis require a kinesin-like protein/RhoGAP complex with microtubule bundling activity. Dev Cell, 2, 41-54.
Neef, R., Preisinger, C., Sutcliffe, J., Kopajtich, R., Nigg, E.A., Mayer, T.U. and Barr, F.A. (2003) Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J Cell Biol, 162, 863-875.
Nemerow, G.R., Mold, C., Schwend, V.K., Tollefson, V. and Cooper, N.R. (1987) Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol, 61, 1416-1420.
Niedobitek, G., Young, L.S. and Herbst, H. (1997) Epstein-Barr virus infection and the pathogenesis of malignant lymphomas. Cancer Surv, 30, 143-162.
Nowak, M.A., Komarova, N.L., Sengupta, A., Jallepalli, P.V., Shih Ie, M., Vogelstein, B. and Lengauer, C. (2002) The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A, 99, 16226-16231.
O''Connell, M.J., Walworth, N.C. and Carr, A.M. (2000) The G2-phase DNA-damage checkpoint. Trends Cell Biol, 10, 296-303.
Otto, S.P. and Whitton, J. (2000) Polyploid incidence and evolution. Annu Rev Genet, 34, 401-437.
Parker, L.L. and Piwnica-Worms, H. (1992) Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science, 257, 1955-1957.
Peng, C.Y., Graves, P.R., Thoma, R.S., Wu, Z., Shaw, A.S. and Piwnica-Worms, H. (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501-1505.
Pietenpol, J.A. and Stewart, Z.A. (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology, 181-182, 475-481.
Pines, J. (1999) Cell cycle. Checkpoint on the nuclear frontier. Nature, 397, 104-105.
Pines, J. (1999) Four-dimensional control of the cell cycle. Nat Cell Biol, 1, E73-79.
Prigent, C. and Dimitrov, S. (2003) Phosphorylation of serine 10 in histone H3, what for? J Cell Sci, 116, 3677-3685.
Rosenthal, E.T., Hunt, T. and Ruderman, J.V. (1980) Selective translation of mRNA controls the pattern of protein synthesis during early development of the surf clam, Spisula solidissima. Cell, 20, 487-494.
Rowe, M., Rowe, D.T., Gregory, C.D., Young, L.S., Farrell, P.J., Rupani, H. and Rickinson, A.B. (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt''s lymphoma cells. Embo J, 6, 2743-2751.
Sanchez, Y., Wong, C., Thoma, R.S., Richman, R., Wu, Z., Piwnica-Worms, H. and Elledge, S.J. (1997) Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science, 277, 1497-1501.
Sbih-Lammali, F., Djennaoui, D., Belaoui, H., Bouguermouh, A., Decaussin, G. and Ooka, T. (1996) Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in north African nasopharyngeal carcinoma. J Med Virol, 49, 7-14.
Sherr, C.J. (1994) G1 phase progression: cycling on cue. Cell, 79, 551-555.
Shimura, M., Tanaka, Y., Nakamura, S., Minemoto, Y., Yamashita, K., Hatake, K., Takaku, F. and Ishizaka, Y. (1999) Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1. Faseb J, 13, 621-637.
Somers, W.G. and Saint, R. (2003) A RhoGEF and Rho family GTPase-activating protein complex links the contractile ring to cortical microtubules at the onset of cytokinesis. Dev Cell, 4, 29-39.
Sorger, P.K., Dobles, M., Tournebize, R. and Hyman, A.A. (1997) Coupling cell division and cell death to microtubule dynamics. Curr Opin Cell Biol, 9, 807-814.
Storchova, Z. and Pellman, D. (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol, 5, 45-54.
Thompson, M.P. and Kurzrock, R. (2004) Epstein-Barr virus and cancer. Clin Cancer Res, 10, 803-821.
Tong, X., Drapkin, R., Reinberg, D. and Kieff, E. (1995) The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2. Proc Natl Acad Sci U S A, 92, 3259-3263.
Tong, X., Drapkin, R., Yalamanchili, R., Mosialos, G. and Kieff, E. (1995) The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol Cell Biol, 15, 4735-4744.
Tong, X., Wang, F., Thut, C.J. and Kieff, E. (1995) The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. J Virol, 69, 585-588.
Tornell, J., Farzad, S., Espander-Jansson, A., Matejka, G., Isaksson, O. and Rymo, L. (1996) Expression of Epstein-Barr nuclear antigen 2 in kidney tubule cells induce tumors in transgenic mice. Oncogene, 12, 1521-1528.
Vanoosthuyse, V., Valsdottir, R., Javerzat, J.P. and Hardwick, K.G. (2004) Kinetochore targeting of fission yeast Mad and Bub proteins is essential for spindle checkpoint function but not for all chromosome segregation roles of Bub1p. Mol Cell Biol, 24, 9786-9801.
Waltzer, L., Logeat, F., Brou, C., Israel, A., Sergeant, A. and Manet, E. (1994) The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. Embo J, 13, 5633-5638.
Wang, F., Gregory, C.D., Rowe, M., Rickinson, A.B., Wang, D., Birkenbach, M., Kikutani, H., Kishimoto, T. and Kieff, E. (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci U S A, 84, 3452-3456.
Wang, L., Grossman, S.R. and Kieff, E. (2000) Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci U S A, 97, 430-435.
Wang, T.H., Wang, H.S., Ichijo, H., Giannakakou, P., Foster, J.S., Fojo, T. and Wimalasena, J. (1998) Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem, 273, 4928-4936.
Wang, X.W., Zhan, Q., Coursen, J.D., Khan, M.A., Kontny, H.U., Yu, L., Hollander, M.C., O''Connor, P.M., Fornace, A.J., Jr. and Harris, C.C. (1999) GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A, 96, 3706-3711.
Wensing, B. and Farrell, P.J. (2000) Regulation of cell growth and death by Epstein-Barr virus. Microbes Infect, 2, 77-84.
Wu, D.Y., Kalpana, G.V., Goff, S.P. and Schubach, W.H. (1996) Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. J Virol, 70, 6020-6028.
Yamaguchi, N., Nakayama, Y., Urakami, T., Suzuki, S., Nakamura, T., Suda, T. and Oku, N. (2001) Overexpression of the Csk homologous kinase (Chk tyrosine kinase) induces multinucleation: a possible role for chromosome-associated Chk in chromosome dynamics. J Cell Sci, 114, 1631-1641.
Zimber-Strobl, U. and Strobl, L.J. (2001) EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol, 11, 423-434.